🇺🇸 FDA
Patent

US 9675618

Drug combinations and uses in treating a coughing condition

granted A61KA61K31/485A61K31/522

Quick answer

US patent 9675618 (Drug combinations and uses in treating a coughing condition) held by Infirst Healthcare Limited expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/485, A61K31/522, A61K45/06